Utah Medical Products Inc (UTMD)
65.29
+0.72
(+1.12%)
USD |
NASDAQ |
Nov 22, 16:00
65.30
+0.01
(+0.02%)
After-Hours: 20:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 221.44M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -19.47% |
Valuation | |
PE Ratio | 15.29 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 5.281 |
Price to Book Value | 1.783 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.305 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.00 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 46.15% |
Profile
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices. |
URL | http://www.utahmed.com |
Investor Relations URL | http://www.utahmed.com/investor-relations.html |
HQ State/Province | Utah |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Small Cap/Blend |
Next Earnings Release | Jan. 30, 2025 (est.) |
Last Earnings Release | Oct. 29, 2024 |
Next Ex-Dividend Date | Dec. 16, 2024 |
Last Ex-Dividend Date | Sep. 20, 2024 |
Ratings
Profile
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices. |
URL | http://www.utahmed.com |
Investor Relations URL | http://www.utahmed.com/investor-relations.html |
HQ State/Province | Utah |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Small Cap/Blend |
Next Earnings Release | Jan. 30, 2025 (est.) |
Last Earnings Release | Oct. 29, 2024 |
Next Ex-Dividend Date | Dec. 16, 2024 |
Last Ex-Dividend Date | Sep. 20, 2024 |